SCShotaro Chubachi

Shotaro Chubachi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shotaro Chubachi has a total of 296 co-authors. Here are the top co-authors by number of shared publications:

  • Koichi Fukunaga

    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

    46 shared publications
  • Shiro Otake

    Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    37 shared publications
  • Kensuke Nakagawara

    Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    29 shared publications
  • Mayuko Watase

    Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    29 shared publications
  • Seishi Ogawa

    Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan

    29 shared publications
  • Takahiro Fukushima

    Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    29 shared publications

Latest Publications

  • Redistribution of Pulmonary Vascular Volume at Upright versus Supine CT

    by Orito Ikeda, Yoshitake Yamada, Minoru Yamada, Yoichi Yokoyama, Mohammed Al Shihry, Shotaro Chubachi, Koichi Fukunaga, Masahiro Jinzaki

    Upright chest CT showed that, compared with CT in the supine position, standing reduced total pulmonary vascular volume, predominantly venous, with a vertical gradient, where dependent lower lung regions exhibited modest volume reduction.


  • Integrative Omics of Eosinophils in Asthma and COPD: Deciphering Molecular Signatures for Targeted Therapy

    by Jun Miyata, Keeya Sunata, Hisashi Sasaki, Shotaro Chubachi, Yoshinori Hasegawa, Yusuke Kawashima, Makoto Arita, Koichi Fukunaga

  • Open Access

    Dietary patterns and food allergies associated with asthma in adults: Findings from an internet-based dietary survey in Japan

    by Mayuko Watase, Takae Tanosaki, Saki Tomiyasu, Katsunori Masaki, Emiko Matsuyama, Kazuki Hamada, Tetsuya Nojiri, Hiroki Kabata, Shotaro Chubachi, Jun Miyata, et al.

  • Estimation of Lung Volume Superimposed on the Mediastinum and Diaphragm on Chest Radiographs Using Upright Multidetector Row CT

    by Yoshitake Yamada, Minoru Yamada, Shotaro Chubachi, Yoichi Yokoyama, Keita Nakatsuka, Naoki Hiraishi, Takayuki Abe, Koichi Fukunaga, Masahiro Jinzaki

    CT-based analysis showed that lung volume superimposed on the mediastinum and diaphragm was lower on upright than supine chest radiographs despite greater lung volume in the upright position.


  • Open Access

    Determinants of high chronic obstructive pulmonary disease assessment test scores according to airflow limitation severity: a three-year prospective study

    by Hideto Iizuka, Hidehiro Irie, Shotaro Chubachi, Keisuke Nishikawa, Takaki Nishizawa, Kohei Fukuzawa, Tetsuya Arai, Takashi Shimada, Shiro Otake, Kaori Sakurai, et al.

    The determinants of chronic obstructive pulmonary disease (COPD) assessment test (CAT) scores according to airflow limitation severity are not fully unders

  • Integrated assessment of total airway count and pneumonia volume on chest computed tomography as a prognostic biomarker for coronavirus disease

    by Kensuke Nakagawara, Naoya Tanabe, Shotaro Chubachi, Tomoki Maetani, Yusuke Shiraishi, Takanori Asakura, Ho Namkoong, Hiromu Tanaka, Takashi Shimada, Shuhei Azekawa, et al.

    Objectives The clinical relevance of computed tomography (CT)-based airway tree structure is unclear. Herein, we used artificial intelligence to segment the airway tree and pneumonia regions, measuring total airway count (TAC) and pneumonia volume to examine whether their combination is more closely associated with clinical outcomes in patients with coronavirus disease (COVID-19) than pneumonia volume alone. Materials and methods We examined clinical data and chest CT from 781 hospitalized COVID-19 patients in a multicenter retrospective cohort in Japan, focusing on the percentage of critical outcomes (high-flow oxygen, invasive mechanical ventilation, or death). Additionally, 197 patients were followed up for 3 months to monitor TAC and pneumonia volume. Results Critical outcomes were observed in 63 (8.8%) patients, with higher TAC in those patients. Patients were divided into four groups based on cutoff values of 17.6% for pneumonia volume percent and 255 for TAC: Group A (low TAC, low pneumonia volume), Group B (high TAC, low pneumonia volume), Group C (low TAC, high pneumonia volume), and Group D (high TAC, high pneumonia volume). Group D had the worst outcomes, highest levels of inflammation, fibrosis markers, and complications, as well as a significantly higher risk of critical outcomes after adjusting for age, body mass index, sex, total lung volume and comorbidities. In the 3-month longitudinal analysis, pneumonia volume, but not TAC, improved in critical cases. Conclusions The integrated assessment of TAC and pneumonia volume effectively predicted critical outcomes in COVID-19 patients and may be useful for various respiratory diseases, including infectious or interstitial pneumonia. Key Points Question Total airway counts (TAC) on computed tomography (CT) scan is associated with respiratory disease progression, but clinical relevance of CT-based airway tree structure is unclear. Findings The integrated assessment of TAC and pneumonia volume effectively predicted critical outcomes in COVID-19 patients. Clinical relevance This metric can potentially be applied to various respiratory diseases, including infectious or interstitial pneumonia. Graphical Abstract

  • Open Access

    Adipose–Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting

    by Takashi Shimada, Shotaro Chubachi, Keisuke Nishikawa, Tetsuya Arai, Hideto Iizuka, Shiro Otake, Kaori Sakurai, Junko Hamamoto, Mamoru Sasaki, Tomoki Maetani, et al.

    Background: Chronic obstructive pulmonary disease (COPD) is frequently associated with cachexia, leading to poor prognoses and reduced quality of life. However, the mechanisms underlying adipose tissue atrophy, its pathological significance and its interaction with skeletal muscle remain poorly understood. We hypothesised that adipose tissue atrophy precedes muscle wasting in COPD‐associated cachexia, and muscle atrophy progresses through adipose–muscle crosstalk. Methods: We analysed chest computed tomography scans of 185 patients with COPD to quantify the cross‐sectional areas of the pectoralis muscle (PM), subcutaneous adipose tissue (SAT) and epicardial adipose tissue (EAT), and the percentage of low attenuation area (LAA%) as an index of emphysema. To elucidate the pathophysiological mechanisms underlying cachexia in COPD, we performed histological and molecular analyses of the lung, muscle and adipose tissues over time in a cigarette smoke–induced emphysema mouse model. Further, we used an in vitro culture system of differentiated adipocytes (3T3‐L1) and myotubes (C2C12) to study the effects of cigarette smoke extract (CSE) on adipose–muscle interaction. Results: In patients with COPD, the areas of PM, SAT and EAT all demonstrated significant negative correlations with LAA%; notably, PM and EAT were independently associated with the extent of emphysematous changes. In the smoke‐exposed murine model, adipose tissue atrophy was observed after 1 month of exposure, accompanied by increased expressions of IL‐6 and IL‐1β, macrophage infiltration and the upregulation of the lipolytic enzymes ATGL and HSL. The adipose atrophy had further progressed after 3 months of exposure, and the high expression of UCP1 was sustained, which suggested the browning of adipose tissue. Conversely, muscle atrophy was not evident at 1 month but became apparent after 3 months, coinciding with emphysema development. This was associated with the downregulation of the myogenic markers MyoD and Myogenin and the upregulation of the muscle degradation marker Atrogin‐1. In vitro experiments revealed that CSE exposure reduced lipid droplet content and induced IL‐6 and IL‐1β expressions in adipocytes. Conditioned media from CSE‐treated adipocytes triggered myotube atrophy and downregulated MyoD and Myogenin but upregulated Atrogin‐1. Conclusions: Our findings indicate that cigarette smoke‐induced adipose tissue atrophy precedes muscle wasting, and alterations in adipose tissue may contribute to muscle atrophy progression. Adipose tissue dysfunction may be implicated in the development of cachexia in patients with COPD, highlighting its potential as a therapeutic target.


  • Open Access

    Consolidation-to-ground-glass opacity ratio on chest CT as a prognostic marker for critical outcomes in COVID-19: a retrospective cohort study

    by Hiromu Tanaka, Naoya Tanabe, Shotaro Chubachi, Tomoki Maetani, Yusuke Shiraishi, Ho Namkoong, Takanori Asakura, Takashi Shimada, Shuhei Azekawa, Shiro Otake, et al.

    Computed tomography (CT)-based quantification of coronavirus disease 2019 (COVID-19) pneumonia is widely performed, and total pneumonia volume, ground-glas

  • Open Access

    CT-based phenotyping of COVID-19: cluster analysis of pulmonary and extrapulmonary imaging markers from a multicentre retrospective cohort study

    by Shiro Otake, Naoya Tanabe, Shotaro Chubachi, Tomoki Maetani, Yusuke Shiraishi, Takanori Asakura, Ho Namkoong, Hiromu Tanaka, Takashi Shimada, Shuhei Azekawa, et al.

    Coronavirus disease 2019 (COVID-19) displays a highly variable clinical course despite advancements in vaccination and antiviral therapies. Chest computed tomography (CT) has become a valuable tool for diagnosing and predicting COVID-19 severity; however, limited studies have explored integrating pulmonary and extrapulmonary CT markers to identify distinct clinical phenotypes. In this study, we aimed to evaluate the utility of cluster analysis, using quantitative pulmonary and extrapulmonary CT indicators, to classify patients with COVID-19 into distinct phenotypic clusters and assess their clinical relevance in predicting disease severity and outcomes. The primary outcome was the rate of critical outcomes (requiring high-flow oxygen therapy or invasive ventilator support or death). In this multicentre, retrospective cohort study, we analysed 1,034 patients with COVID-19 from four hospitals in Japan. Hierarchical cluster analysis was performed using age, sex, and seven imaging markers: pneumonia volume, muscle area, muscle density, subcutaneous and visceral fat indices, bone density, and coronary artery calcification score. Clinical characteristics, laboratory findings, and outcomes were compared across the identified clusters. Four distinct clusters were identified. Cluster 1 consisted of younger individuals with minimal pneumonia and favourable extrapulmonary organ markers, exhibiting the best clinical outcomes. Cluster 2 included younger patients with high pneumonia volume and visceral fat accumulation, exhibiting poor respiratory outcomes. Cluster 3 comprised older individuals with mild fat accumulation and low bone density, with intermediate severity. Cluster 4 presented the highest pneumonia volume, extensive visceral fat, and coronary artery calcification, resulting in the worst overall prognosis, including the highest mortality and in-hospital complications. Clustering based on pulmonary and extrapulmonary CT indicators enabled the precise classification of patients with COVID-19 into clinically significant subgroups with distinct outcomes. This study highlights the importance of integrating multiple imaging markers for disease phenotyping and prognosis.

  • Open Access

    A systematic review and meta-analysis of risk factors for long COVID

    by Kensuke Nakagawara, Shiro Otake, Nobuyuki Horita, Ho Namkoong, Hideki Terai, Ryo Takemura, Kengo Nagashima, Shotaro Chubachi, Koichi Fukunaga

    Background Since the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), its long-term sequelae, collectively known as long COVID, have received increasing attention. However, many uncertainties remain regarding the risk factors for long COVID, including its associations with comorbidities and vaccination status. Therefore, we conducted a systematic review and meta-analysis to comprehensively evaluate the risk factors associated with long COVID. Methods We performed a searched in the PubMed database in December 2024 (CRD 42025626341) and retrieved studies that evaluated the risk of long COVID development in patients following infection with SARS-CoV-2. Adjusted odds ratios (OR) for each outcome were synthesized using a random effects model, and risk factors for long COVID were analyzed. Results 69 studies were identified from 45 countries. The results of the meta-analysis suggested that older age (OR, 1.23; 95% confidence interval [CI], 1.08–1.40), middle age (OR, 1.59; 95% CI, 1.42–1.79), and female sex (OR, 1.38; 95% CI, 1.30–1.46) were the most significant risk factors for long COVID. In addition, comorbidities such as obesity (OR, 1.28; 95% CI, 1.15–1.42), respiratory disease (OR, 1.43; 95% CI, 1.28–1.59), anxiety (OR, 1.22; 95% CI, 1.08–1.38), and depression (OR, 1.19; 95% CI, 1.04–1.37) were identified as risk factors. Hospitalization due to acute COVID-19 (OR, 2.06; 95% CI, 1.81–2.34) and non-vaccination (OR, 1.31; 95% CI, 1.18–1.46) were also identified as significant risk factors for long COVID. Conversely, infection with the Omicron variant was associated with substantially reduced risk for long COVID (OR, 0.59; 95% CI, 0.47–0.73). Conclusion Based on our systematic review and meta-analysis, we identified several risk factors for long COVID that differ from those associated with acute phase severity. Our findings provide valuable insights, contributing to the prevention of long COVID.